All stock lists
Heron Therapeutics, Inc. /De/ (NASDAQ:HRTX)
US · Delayed Price · Currency is USD
Also listed: 0J4V.LHealthcare · Biotechnology
0.28-0.01 (-3.52%)
Market cap
$54.1M
Insider Score
Health Score
Analyst consensus
Listed since
Aug 26, 1987
Website
Insider Score
––Not scored
HRTX Insider Score
Insiders here have filed 14 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
HRTX analyst forecast
HRTX analyst consensus
Hold1 ratings
Buy 0 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
HRTX 12-month price target
No published price targets in the last 12 months.
HRTX ratings mix, last 12 months
Buy Hold Sell
Best analysts covering HRTX
No firm covering HRTX has enough calls with a finished 1Y holding period to rank yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
HRTX analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Neutral | — | — | Downgraded | 2026-08-11 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-06-03 |
| — | Needham | Hold | — | — | Downgraded | 2026-06-03 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-01-09 |
| — | Needham | Buy | — | — | Reiterated | 2025-08-08 |
| — | Needham | Buy | — | — | Reiterated | 2025-04-11 |
| — | Needham | Buy | — | — | Reiterated | 2025-02-28 |
| — | Needham | Buy | — | — | Reiterated | 2024-12-04 |
| — | Needham | Buy | — | — | Reiterated | 2024-11-13 |
| — | Needham | Buy | — | — | Reiterated | 2024-09-25 |
| — | Needham | Buy | — | — | Reiterated | 2024-08-07 |
| — | Needham | Buy | — | — | Reiterated | 2024-05-16 |
| — | Needham | Buy | — | — | Reiterated | 2024-05-08 |
| — | Needham | Buy | — | — | Reiterated | 2024-04-11 |
| — | Needham | Buy | — | — | Reiterated | 2024-03-13 |
| — | Needham | Buy | — | — | Reiterated | 2023-11-15 |
| — | Needham | Buy | — | — | Reiterated | 2023-08-15 |
| — | Needham | Buy | — | — | Reiterated | 2023-07-25 |
| — | Needham | Buy | — | — | Reiterated | 2023-05-12 |
| — | Needham | Buy | — | — | Reiterated | 2023-04-21 |
| — | Needham | Buy | — | — | Reiterated | 2023-03-24 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2023-03-24 |
| — | Needham | Buy | — | — | Reiterated | 2022-11-09 |
| — | Needham | Buy | — | — | Reiterated | 2022-06-30 |
| — | Needham | Buy | — | — | Reiterated | 2022-05-10 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2020-12-02 |
| — | Guggenheim | Buy | — | — | Reiterated | 2020-05-27 |
| — | Needham | Buy | — | — | Reiterated | 2020-03-02 |
| — | Needham | Buy | — | — | Reiterated | 2020-02-20 |
| — | JMP Securities | Outperform | — | — | Reiterated | 2019-10-03 |
| — | Stifel Nicolaus | Buy | — | — | Reiterated | 2018-09-14 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2018-07-19 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2018-06-22 |
| — | Evercore ISI Group | Outperform | — | — | Reiterated | 2018-06-21 |
| — | Leerink Swann | Outperform | — | — | Reiterated | 2018-01-03 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2017-10-31 |
| — | Northland Securities | Outperform | — | — | Reiterated | 2017-09-27 |
| — | Mizuho | Buy | — | — | Reiterated | 2017-09-27 |
| — | Needham | Buy | — | — | Reiterated | 2017-02-27 |
| — | Aegis Capital | Buy | — | — | Reiterated | 2016-10-26 |
| — | Jefferies | Buy | — | — | Reiterated | 2016-10-03 |
| — | Cantor Fitzgerald | Buy | — | — | Reiterated | 2016-05-02 |
| — | Lake Street | Buy | — | — | Reiterated | 2015-12-10 |
| — | Brean Capital | Buy | — | — | Reiterated | 2015-09-23 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2015-09-23 |
| — | Jefferies | Buy | — | — | Reiterated | 2015-09-23 |
| — | Bank of America | Buy | — | — | Reiterated | 2015-09-02 |
| — | JMP Securities | Hold | — | — | Downgraded | 2015-08-19 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2015-06-30 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2015-06-26 |
| — | Leerink Swann | Outperform | — | — | Reiterated | 2015-06-19 |
| — | Leerink Swann | Outperform | — | — | Reiterated | 2015-06-01 |
| — | JMP Securities | Market Outperform | — | — | Reiterated | 2015-05-29 |
| — | Jefferies | Buy | — | — | Reiterated | 2015-03-20 |
| — | Leerink Swann | Outperform | — | — | Reiterated | 2015-03-18 |
| — | Noble Financial | Buy | — | — | Reiterated | 2014-08-07 |
HRTX earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2025-11-04 | -0.01 | -0.05 | $39.0M | $38.2M |
| 2026-02-26 | -0.03 | -0.02 | $39.9M | $40.6M |
| 2026-05-11 | -0.03 | -0.04 | $36.7M | $34.7M |
| 2026-08-10 | -0.01 | -0.03 | $42.2M | $37.7M |
| 2026-11-09Upcoming | -0.03 | — | $37.5M | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.